← Back to Clinical Trials
Recruiting NCT06500351

Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Postpartum. Hypertension

Trial Parameters

Condition Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Patients With Postpartum Hypertension
Sponsor Sohag University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 90
Sex FEMALE
Min Age 18 Years
Max Age 45 Years
Start Date 2024-06-25
Completion 2025-06-25

Brief Summary

This is an observertional study aimed at Study the association between Renalase(rs10887800) Genotyping \& Leucocytes telomere length in patients with postpartum hypertension whether new onset( denovo) or persistent following pregnancy complicated by hypertension.

Eligibility Criteria

Inclusion Criteria: * Patients who are18 years or above, and have a diagnosis of postpartum hypertension(regardless of where they received their antenatal care) attended to Sohag university hospitals Exclusion Criteria: * All pregnant women with medical disorders in pregnancy other than Hypertensive disorders during pregnancy (e.g., sickle cell disease, heart disease, kidney and other connective tissues disorders) will be excluded from the study. Also we excluded measurements taken during scheduled or unscheduled surgical encounters given potential for interaction with anesthetic agents

Related Trials